 |
MGA News |
|
We have been advised by ICN that the Mestinon Prolonged Release Tablets (180 mg) are now available for prescription on a named patient basis from your consultant.
It is understood that these are not suitable for all people under all circumstances and therefore it is essential that you discuss your personal circumstances with your Consultant before taking these tablets.
 |
 |
Notices | Search | Publications | What's New? | Myasthenia Gravis | Research | Top |
| Organisation | Fundraising | Branches | Regions | Contacts | Newsletter | Home Page | |
|
|
MGA Forum | Press & Publicity |
|
For Comments and enquiries about the design of this website: email webmaster . All other enquiries and comments should be directed to the MGA headquarters. Updated 15-Jan-2008Registered Charity (England and Wales) No 1046443
|
|